Bispecific binding agents
US9133272B2 · kind B2 · utility
2Cited by
59References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 29, 2012 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | Feb 29, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to bispecific anti-sclerostin/anti-DKK1 binding agents and combinations of anti-sclerostin and anti-DKK1 binding agents, and related methods of treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.